HAT1
HAT1 (histone acetyltransferase 1, also known as KAT1) is a type B histone acetyltransferase that acetylates newly synthesised cytoplasmic histones before their import into the nucleus. It belongs to the HAT1 family and to the lysine acetyltransferase gene group. Browse Assay Genie's current range of HAT1 research reagents below, or read on for the biology behind the target.
HAT1 is a type B histone acetyltransferase involved in the rapid acetylation of newly synthesised cytoplasmic histones. These histones are then imported into the nucleus for de novo deposition onto nascent DNA chains. Histone acetylation, particularly of histone H4, plays an important role in replication-dependent chromatin assembly. The enzyme acetylates soluble but not nucleosomal histone H4 at lysines 5 and 12, and to a lesser degree histone H2A at lysine 5.
The HAT1 gene encodes the histone acetyltransferase type B catalytic subunit, which belongs to the HAT1 family and is classed by HGNC within the lysine acetyltransferases. The enzyme carries the EC number 2.3.1.48. UniProt records its localisation to the nucleus (including the nucleoplasm and nuclear matrix), the cytoplasm and the mitochondrion. Alternatively spliced transcript variants have been identified for this gene. Orthologues are annotated in both mouse and rat as Hat1.
HAT1 also has a role in infection biology. In the context of hepatitis B virus (HBV), it contributes to viral replication by acetylating histone H4 at lysines 5 and 12 on the covalently closed circular DNA (cccDNA) minichromosome, leading to the accumulation of cccDNA within the host cell. The symbol KAT1 is an alternative name for the same gene, reflecting its place among the lysine acetyltransferases. Researchers studying HAT1 often work with a HAT1 antibody or HAT1 ELISA kit to examine expression of the HAT1 protein.
HAT1 acetylates newly synthesised histone H4 before nuclear import, making it central to studies of replication-dependent chromatin assembly.
Its selectivity for soluble histone H4 at lysines 5 and 12, and histone H2A at lysine 5, makes HAT1 a model for site-specific acetylation.
HAT1 acetylates histone H4 on the HBV cccDNA minichromosome, contributing to cccDNA accumulation in the host cell.
As a member of the lysine acetyltransferase group, HAT1 is studied for how acetyltransferase activity shapes histone marks and nuclear function.
HAT1 is a type B histone acetyltransferase that rapidly acetylates newly synthesised cytoplasmic histones, which are then imported into the nucleus and deposited onto nascent DNA. It acts on soluble, not nucleosomal, histone H4 at lysines 5 and 12, and to a lesser degree on histone H2A at lysine 5.
HAT1 is the approved HGNC symbol for histone acetyltransferase 1, and KAT1 is a recorded alias. UniProt names the protein histone acetyltransferase type B catalytic subunit. NCBI Gene reports that alternatively spliced transcript variants have been identified for this gene.
UniProt reports that HAT1 contributes to hepatitis B virus replication by acetylating histone H4 at lysines 5 and 12 on the cccDNA minichromosome, leading to its accumulation. Orthologues exist in mouse and rat, both named Hat1; check the datasheet of any product for its validated reactivity.
Other lysine acetyltransferases, histone-modifying enzymes and chromatin-assembly targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O14929; product specifications from Assay Genie datasheets.